查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球乳房切片市場：市場規模、佔有率、成長分析、類型、應用 - 產業預測，2023-2030 年
市場調查報告書
商品編碼
1396196

全球乳房切片市場：市場規模、佔有率、成長分析、類型、應用 - 產業預測，2023-2030 年

Global Breast Biopsy Market Size, Share, Growth Analysis, By Type(Vacuum assisted biopsy, core needle biopsy and fine needle aspiration biopsy), By Application(Hospitals and clinics, diagnostic centres) - Industry Forecast 2023-2030
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2021年全球乳腺活檢市場規模為 7.9 億美元，預計將從 2022 年的 8.5 億美元增長到 2030 年的 16.3 億美元，在預測期間（2023~2030 年）的複合年增長率為 8.4%。

全球乳房切片市場涵蓋各種旨在評估乳房組織是否有潛在異常和乳癌跡象的診斷程序，是醫療保健行業中一個充滿活力且快速擴張的市場。這就是我所工作的領域。推動這一市場的關鍵因素包括全球乳癌發病率上升、對早期檢測和診斷的日益重視、診斷成像方式和切片檢查技術的進步以及對微創手術的日益偏好。市場提供多種切片檢查方法，包括粗針穿刺切片、真空輔助切片檢查、細針抽吸和手術切片檢查。一個顯著的趨勢是擴大採用影像引導切片檢查，例如超音波引導切片檢查、乳房 X 光檢查引導切片檢查和磁振造影(MRI) 引導切片檢查，這提高了準確性，而且準確性正在不斷提高。此外，自動切片檢查槍、手持式切片檢查設備和立體定位切片檢查系統等創新切片檢查設備和系統的出現提高了手術效率和患者舒適度。儘管北美目前由於乳癌發病率高、醫療基礎設施發達以及有利的報銷政策而在全球市場佔據主導地位，但亞太和拉丁美洲的新興國家預計將顯著成長。促成這一成長的因素包括醫療保健支出的增加、醫療設施的改善以及對乳癌篩檢意識的提高。總之，隨著醫療保健系統優先考慮乳癌的早期檢測和準確診斷，全球乳房切片市場預計將顯著擴大，最終改善患者的治療結果並降低死亡率。

自上而下和自下而上的方法已用於估計和檢驗全球乳房切片市場的規模，並估計其他各個相關子市場的規模。用於估計市場規模的調查方法包括以下細節：確定市場主要企業的二次研究以及確定各自區域的市場佔有率的主要和二次研究。整個過程包括研究主要企業的年度和財務報告以及廣泛的採訪，以獲得執行長、副總裁、董事和行銷負責人等行業領導者的重要見解。所有佔有率比率和細目分類均使用二手資訊確定並使用主要資訊檢驗。本研究涵蓋的所有可能影響市場的參數都經過了詳細的考慮和研究，透過初步研究檢驗和分析，以獲得最終的定量和定性資料。

乳房切片全球市場細分分析

全球乳房切片市場按類型、應用和地區細分。按類型分類，市場分為真空輔助切片檢查、粗針穿刺切片和細針抽吸切片檢查。根據應用，市場分為醫院/診所和診斷中心。從區域來看，市場分為北美、歐洲、亞太地區、中東和非洲以及拉丁美洲。

全球乳房切片市場的促進因素

乳癌發生率增加：

全球乳房切片市場的主要促進因素是全球乳癌發生率的上升。作為全球最常見的癌症之一，乳癌的發生率持續上升。乳癌病例數的這些趨勢凸顯了早期檢測、診斷和治療的日益重要性，並推動了對乳房切片的需求。準確可靠的診斷技術對於識別乳房異常並促進及時干預的必要性極大地促進了乳房切片市場的成長。

全球乳房切片市場的抑制因素

假陰性或假陽性的可能性：

全球乳房切片市場的一個重要抑制因素是假陰性和假陽性的可能性。乳房切片在診斷乳癌中發揮至關重要的作用，但存在錯誤結果的固有風險。當切片檢查中未檢測到癌細胞時，就會出現假陰性結果，導致延遲或漏診。相反，假陽性結果可能會給患者帶來不必要的焦慮、額外的檢測和侵入性操作。這些診斷準確性的限制損害了乳房切片程序的可靠性，並為醫療保健專業人員和患者做出資訊的治療決策帶來了挑戰。

全球乳房切片市場趨勢

全球乳房切片市場的主要趨勢是擴大採用影像引導切片檢查技術。超音波引導切片檢查、乳房X光檢查引導切片檢查和磁振造影（MRI）引導切片檢查等技術越來越受歡迎。這些方法利用先進的顯像模式來精確定位和收集可疑的乳房病變，與傳統切片檢查方法相比，提高了準確性並減少了侵入性。即時影像導引有助於目標部位的可視化，從而提高診斷率並最大限度地減少重複手術的需要。影像導引切片檢查的日益普及反映了該行業致力於提高乳房切片手術的準確性和效率，同時優先考慮患者舒適度並降低手術風險。Masu。

目錄

  • 執行摘要
  • 調查方法
  • 母市場分析
  • 主要市場考察
    • 技術分析
    • 價格分析
    • 供應鏈分析
    • 價值鏈分析
    • 市場生態系統
    • 智慧財產權分析
    • 貿易分析
    • Start-Ups分析
    • 原料分析
    • 創新矩陣
    • 研發線產品分析
    • 總體經濟指標
    • 主要投資分析
    • 關鍵成功因素
    • 競爭程度
  • 市場動態及展望
    • 市場動態
      • 促進因素
      • 機會
      • 抑制因素
      • 任務
    • 監管形勢
    • 波特的分析
    • 對未來中斷的特殊考察
  • 全球乳房切片市場：按類型
    • 市場概況
    • 真空輔助切片檢查
    • 空心針切片和細針抽吸切片檢查
  • 全球乳房切片市場：按應用分類
    • 市場概況
    • 醫院和診所
    • 診斷中心
  • 全球乳房切片市場規模：按地區
    • 市場概況
    • 北美洲
      • 美國
      • 加拿大
    • 歐洲
      • 德國
      • 西班牙
      • 法國
      • 英國
      • 其他歐洲國家地區
    • 亞太地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 其他亞太地區
    • 拉丁美洲
      • 巴西
      • 其他拉丁美洲地區
    • 中東和非洲 (MEA)
      • 海灣合作理事會國家
      • 南非
      • 其他中東/非洲地區
  • 競爭形勢
    • 前5名企業對比
    • 主要企業市場定位（2021年）
    • 主要市場參與者所採取的策略
    • 關鍵成功策略
    • 近期市集活動
    • 主要企業市場佔有率（2021年）
  • 主要企業簡介
    • Ethicon Endo Surgery
    • CR Bard, Inc.
    • Becton and Dickinson Company
    • Leica Biosystems Nussloch GmbH
    • Encapsule Medical Devices LLC.
    • Hologic Inc.
    • Intact Medical Corporation
    • Galini SRL
    • Argon Medical Devices
    • Cook Medical Incorporated
    • Medtronic plc
    • Devicor Medical Products, Inc.
    • Carestream Health, Inc.
    • Planmed Oy
    • NIPRO Medical Corporation
    • Seno Medical Instruments, Inc.
    • Scion Medical Technologies LLC
    • Biopsybell Srl
    • STERYLAB Srl
    • Medicon Hellas SA
簡介目錄
Product Code: SQMIG35A2467

Global Breast Biopsy Market size was valued at USD 0.79 billion in 2021 and is poised to grow from USD 0.85 billion in 2022 to USD 1.63 billion by 2030, at a CAGR of 8.4% during the forecast period (2023-2030).

The global breast biopsy market stands as a dynamic and rapidly expanding sector within the healthcare industry, encompassing various diagnostic procedures aimed at assessing breast tissue for potential abnormalities or signs of breast cancer. Key drivers propelling this market include the escalating worldwide incidence of breast cancer, a growing emphasis on early detection and diagnosis, advancements in imaging modalities and biopsy techniques, and an increasing preference for minimally invasive procedures. The market offers a diverse array of biopsy methods, including core needle biopsy, vacuum-assisted biopsy, fine needle aspiration, and surgical biopsy. A notable trend is the rising adoption of image-guided biopsy procedures such as ultrasound-guided, mammography-guided, and magnetic resonance imaging (MRI)-guided biopsies, providing heightened accuracy and precision. Additionally, the market is witnessing the emergence of innovative biopsy devices and systems, including automated biopsy guns, handheld biopsy devices, and stereotactic biopsy systems, enhancing procedural efficiency and patient comfort. While North America currently dominates the global market due to high breast cancer prevalence, well-established healthcare infrastructure, and favorable reimbursement policies, emerging economies in Asia-Pacific and Latin America are anticipated to experience significant growth. Factors contributing to this growth include increasing healthcare expenditure, improved healthcare facilities, and rising awareness about breast cancer screening. In summary, the global breast biopsy market is poised for substantial expansion as healthcare systems prioritize early detection and precise diagnosis of breast cancer, ultimately leading to improved patient outcomes and reduced mortality rates.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Breast Biopsy Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Breast Biopsy Market Segmental Analysis

The Global Breast Biopsy Market is segmented by type, application, and region. Based on type, the market can be segmented into Vacuum assisted biopsy, core needle biopsy and fine needle aspiration biopsy. Based on application, the market is segmented into Hospitals and clinics, diagnostic centres. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Breast Biopsy Market

Increasing Incidence of Breast Cancer:

A key driver for the Global Breast Biopsy Market is the escalating worldwide incidence of breast cancer. As one of the most prevalent cancers globally, the frequency of breast cancer has been consistently on the rise. This upward trend in breast cancer cases underscores the increasing importance of early detection, diagnosis, and treatment, thereby boosting the demand for breast biopsy procedures. The imperative for accurate and reliable diagnostic techniques to identify breast abnormalities and facilitate timely intervention has significantly contributed to the growth of the breast biopsy market.

Restraints in the Global Breast Biopsy Market

Potential for False-Negative or False-Positive Results:

A notable restraint for the Global Breast Biopsy Market is the potential for false-negative or false-positive results. While breast biopsies play a pivotal role in diagnosing breast cancer, the inherent risk of erroneous outcomes exists. False-negative results may occur when the biopsy fails to detect cancerous cells, leading to delayed or missed diagnoses. Conversely, false-positive results can induce unnecessary anxiety, additional testing, and potentially invasive procedures for patients. These limitations in diagnostic accuracy can undermine confidence in the reliability of breast biopsy procedures, posing challenges to healthcare providers and patients in making informed treatment decisions.

Market Trends of the Global Breast Biopsy Market

A key trend in the global breast biopsy market is the increasing adoption of image-guided biopsy techniques. Techniques such as ultrasound-guided, mammography-guided, and magnetic resonance imaging (MRI)-guided biopsies have gained significant popularity. These methods leverage advanced imaging modalities to precisely target and sample suspicious breast lesions, offering improved accuracy and reduced invasiveness compared to traditional biopsy methods. Real-time imaging guidance enhances visualization of the target area, resulting in better diagnostic yield and minimizing the need for repeated procedures. The growing adoption of image-guided biopsies reflects the industry's commitment to enhancing the accuracy and efficiency of breast biopsy procedures while prioritizing patient comfort and reducing procedural risks.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
    • Regulatory Landscape
    • Porters Analysis
      • Competitive rivalry
      • Threat of Substitute Products
      • Bargaining Power of Buyers
      • Threat of New Entrants
      • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
      • Political Impact
      • Economic Impact
      • Social Impact
      • Technical Impact
      • Environmental Impact
      • Legal Impact
  • Global Breast Biopsy Market by Type
    • Market Overview
    • Vacuum assisted biopsy
    • core needle biopsy and fine needle aspiration biopsy
  • Global Breast Biopsy Market by Application
    • Market Overview
    • Hospitals and clinics
    • diagnostic centres
  • Global Breast Biopsy Market Size by Region
    • Market Overview
    • North America
      • USA
      • Canada
    • Europe
      • Germany
      • Spain
      • France
      • UK
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia-Pacific
    • Latin America
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (MEA)
      • GCC Countries
      • South Africa
      • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
      • By Development
      • By Company
      • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Ethicon Endo Surgery (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • C. R. Bard, Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Becton and Dickinson Company (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Leica Biosystems Nussloch GmbH (Germany)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Encapsule Medical Devices LLC. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Hologic Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Intact Medical Corporation (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Galini SRL (Italy)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Argon Medical Devices (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Cook Medical Incorporated (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Medtronic plc (Ireland)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Devicor Medical Products, Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Carestream Health, Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Planmed Oy (Finland)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • NIPRO Medical Corporation (Japan)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Seno Medical Instruments, Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Scion Medical Technologies LLC (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Biopsybell S.r.l. (Italy)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • STERYLAB S.r.l. (Italy)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Medicon Hellas S.A. (Greece)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments